BNA’s Health Care Daily Report™ sets the standard for reliable, high-intensity coverage of breaking health care news, covering all major legal, policy, industry, and consumer developments in a...
By James Swann
The Department of Health and Human Services Office of Inspector General will conduct a limited, four-state review of the Centers for Medicare & Medicaid Services' competitive bidding program for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS).
The review, which will cover Maryland, Michigan, Ohio and Tennessee, comes in response to a June 20 request from Reps. Glenn Thompson (R-Pa.) and Bruce L. Braley (D-Iowa) to investigate licensure issues and identify whether unlicensed DMEPOS providers were awarded contracts by CMS under the bidding program (122 HCDR, 6/25/13).
Braley and Thompson said there had been indications that CMS awarded contracts to DMEPOS providers who were not compliant with program guidelines.
In an Aug. 22 letter to Thompson and Braley, OIG Inspector General Daniel R. Levinson said the limited review would determine how CMS applied “State licensing requirements under Round 2 of the bidding program in these States to suppliers that were awarded contracts.”
In addition, Levinson said, OIG will determine the impact to the competitive bidding program from any potential licensing issues in the four states.
Levinson also said OIG will begin work this year to conduct a full post-award review of Round 2 of the competitive bids program.
The competitive bids program expanded from nine areas to 91 additional areas for Round 2, which began July 1. The new areas include Los Angeles and Chicago. Thompson and Braley have initiated congressional letters to CMS in attempts to delay the second round of the bidding program.
When the 800 suppliers chosen to provide products in the eight categories of Round Two were announced in April, CMS said that the program is expected to save Medicare Part B about $25.7 billion between 2013 and 2022 and that beneficiaries are expected to save an estimated $17.1 billion as a result of lower coinsurance and premium payments (69 HCDR, 4/10/13).
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)